DFD-16897-59182
2 vaccinations
11 coded responses
25 check-ins
11 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 917 / CA
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-30
Registered in v-safe
-
2021-03-30
Dose 1 — Moderna
- 2021-03-30
- 2021-03-31
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Nausea, Abdominal painAdult check-in
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Nausea, Abdominal painAdult check-in
-
2021-04-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Nausea, Abdominal painAdult check-in
- 2021-04-05
- 2021-04-06
-
2021-04-13
Survey response — day 14, dose 1MedDRA: Dyspepsia, Erythema, Nausea — Feeling: GoodFree text: Nausea, dyspepsia.Redness at deltoid site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-20
-
2021-04-27
Dose 2 — Moderna
-
2021-04-27
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-28
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Increased Blood Glucose LevelMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Further increase in Blood Glucose levelMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased, Night sweats — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Continue elevated glucose level. Night sweating.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased — Feeling: Good · Site: Pain, Swelling · Headache, Muscle or body aches, Nausea, Abdominal painFree text: Glucose level lower, still elevatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-02
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose abnormal — Feeling: Good · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painFree text: Glucose returning to normal rangeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, Abdominal painFree text: Glucose level improvementMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-04
Survey response — day 7, dose 2MedDRA: Blood glucose increased — Feeling: Good · Site: Pain · Muscle or body aches, Nausea, Abdominal painFree text: Glucose level elevatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-11
-
2021-05-18
Survey response — day 21, dose 2MedDRA: Dizziness — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Light headedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-25
Survey response — day 28, dose 2MedDRA: Asthenia, Headache, Injection site discomfort, Nausea, Syncope — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Syncope, discomfort at injection site, increased nausea and weakness headache in early hours upon wakingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-01
Survey response — day 35, dose 2MedDRA: Abdominal discomfort, Disorientation, Hyperglycaemia, Syncope — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Strange abdomen discomfort, rates 2, periods hyperglycemia, mild syncope, and mild disorientation.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-08
- 2021-07-27
- 2021-10-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Moderna | |
| 2 | 2021-04-27 | Moderna |
Free text
Release 7 — day 14, dose 1
Symptoms: Nausea, dyspepsia.Redness at deltoid site.
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Increased Blood Glucose Level
Systemic reaction (other): Further increase in Blood Glucose level
Systemic reaction (other): Continue elevated glucose level. Night sweating.
Systemic reaction (other): Glucose level lower, still elevated
Systemic reaction (other): Glucose returning to normal range
Systemic reaction (other): Glucose level improvement
Release 8 — day 7, dose 2
Systemic reaction (other): Glucose level elevated
Release 8 — day 21, dose 2
Symptoms: Light headed
Release 8 — day 28, dose 2
Symptoms: Syncope, discomfort at injection site, increased nausea and weakness headache in early hours upon waking
Release 8 — day 35, dose 2
Symptoms: Strange abdomen discomfort, rates 2, periods hyperglycemia, mild syncope, and mild disorientation.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | ✓ | ✓ | ✓ |
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Disorientation | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Dyspepsia | ✓ | ✓ | ✓ |
| SD | Erythema | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hyperglycaemia | ✓ | ✓ | ✓ |
| SD | Injection site discomfort | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Syncope | ✓ | ✓ | ✓ |
| SRO | Blood glucose abnormal | ✓ | ✓ | ✓ |
| SRO | Blood glucose increased | ✓ | ✓ | ✓ |
| SRO | Night sweats | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release